FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289833892> ?p ?o ?g. }

• W4289833892 endingPage "498" @default.
• W4289833892 startingPage "487" @default.
• W4289833892 abstract "The prognostic importance of local failure after definitive radiotherapy (RT) in National Comprehensive Cancer Network intermediate- and high-risk prostate cancer (PCa) patients remains unclear.To evaluate the prognostic impact of local failure and the kinetics of distant metastasis following RT.A pooled analysis was performed on individual patient data of 12 533 PCa (6288 high-risk and 6245 intermediate-risk) patients enrolled in 18 randomized trials (conducted between 1985 and 2015) within the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium. Multivariable Cox proportional hazard (PH) models were developed to evaluate the relationship between overall survival (OS), PCa-specific survival (PCSS), distant metastasis-free survival (DMFS), and local failure as a time-dependent covariate. Markov PH models were developed to evaluate the impact of specific transition states.The median follow-up was 11 yr. There were 795 (13%) local failure events and 1288 (21%) distant metastases for high-risk patients and 449 (7.2%) and 451 (7.2%) for intermediate-risk patients, respectively. For both groups, 81% of distant metastases developed from a clinically relapse-free state (cRF state). Local failure was significantly associated with OS (hazard ratio [HR] 1.17, 95% confidence interval [CI] 1.06-1.30), PCSS (HR 2.02, 95% CI 1.75-2.33), and DMFS (HR 1.94, 95% CI 1.75-2.15, p < 0.01 for all) in high-risk patients. Local failure was also significantly associated with DMFS (HR 1.57, 95% CI 1.36-1.81) but not with OS in intermediate-risk patients. Patients without local failure had a significantly lower HR of transitioning to a PCa-specific death state than those who had local failure (HR 0.32, 95% CI 0.21-0.50, p < 0.001). At later time points, more distant metastases emerged after a local failure event for both groups.Local failure is an independent prognosticator of OS, PCSS, and DMFS in high-risk and of DMFS in intermediate-risk PCa. Distant metastasis predominantly developed from the cRF state, underscoring the importance of addressing occult microscopic disease. However a second wave of distant metastases occurs subsequent to local failure events, and optimization of local control may reduce the risk of distant metastasis.Among men receiving definitive radiation therapy for high- and intermediate-risk prostate cancer, about 10% experience local recurrence, and they are at significantly increased risks of further disease progression. About 80% of patients who develop distant metastasis do not have a detectable local recurrence preceding it." @default.
• W4289833892 created "2022-08-05" @default.
• W4289833892 creator A5005238316 @default.
• W4289833892 creator A5008514077 @default.
• W4289833892 creator A5014871240 @default.
• W4289833892 creator A5015145551 @default.
• W4289833892 creator A5016754892 @default.
• W4289833892 creator A5019525982 @default.
• W4289833892 creator A5019527975 @default.
• W4289833892 creator A5020809971 @default.
• W4289833892 creator A5021116939 @default.
• W4289833892 creator A5022999007 @default.
• W4289833892 creator A5023340968 @default.
• W4289833892 creator A5024741202 @default.
• W4289833892 creator A5025921361 @default.
• W4289833892 creator A5027101830 @default.
• W4289833892 creator A5036530578 @default.
• W4289833892 creator A5037579052 @default.
• W4289833892 creator A5038819739 @default.
• W4289833892 creator A5041059810 @default.
• W4289833892 creator A5041615709 @default.
• W4289833892 creator A5044798896 @default.
• W4289833892 creator A5045162411 @default.
• W4289833892 creator A5046387277 @default.
• W4289833892 creator A5048513152 @default.
• W4289833892 creator A5054046130 @default.
• W4289833892 creator A5054385545 @default.
• W4289833892 creator A5059261043 @default.
• W4289833892 creator A5059578608 @default.
• W4289833892 creator A5059609929 @default.
• W4289833892 creator A5059792318 @default.
• W4289833892 creator A5060371062 @default.
• W4289833892 creator A5062426661 @default.
• W4289833892 creator A5071909609 @default.
• W4289833892 creator A5075740763 @default.
• W4289833892 creator A5076238068 @default.
• W4289833892 creator A5082004047 @default.
• W4289833892 creator A5085092777 @default.
• W4289833892 creator A5085318253 @default.
• W4289833892 creator A5085730505 @default.
• W4289833892 creator A5085787232 @default.
• W4289833892 creator A5085868823 @default.
• W4289833892 creator A5089472018 @default.
• W4289833892 creator A5090975999 @default.
• W4289833892 date "2022-11-01" @default.
• W4289833892 modified "2023-10-14" @default.
• W4289833892 title "Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)" @default.
• W4289833892 cites W1870480275 @default.
• W4289833892 cites W1988691059 @default.
• W4289833892 cites W1999045406 @default.
• W4289833892 cites W2005501262 @default.
• W4289833892 cites W2024703759 @default.
• W4289833892 cites W2036880254 @default.
• W4289833892 cites W2050146329 @default.
• W4289833892 cites W2054899405 @default.
• W4289833892 cites W2067125737 @default.
• W4289833892 cites W2068325458 @default.
• W4289833892 cites W2086158679 @default.
• W4289833892 cites W2087338584 @default.
• W4289833892 cites W2108864389 @default.
• W4289833892 cites W2125785593 @default.
• W4289833892 cites W2151644213 @default.
• W4289833892 cites W2156391988 @default.
• W4289833892 cites W2163120057 @default.
• W4289833892 cites W2276711621 @default.
• W4289833892 cites W2296809578 @default.
• W4289833892 cites W2316095838 @default.
• W4289833892 cites W2620746860 @default.
• W4289833892 cites W2743350540 @default.
• W4289833892 cites W2781827966 @default.
• W4289833892 cites W2789775641 @default.
• W4289833892 cites W2791655860 @default.
• W4289833892 cites W2806842723 @default.
• W4289833892 cites W2987877358 @default.
• W4289833892 cites W2992969809 @default.
• W4289833892 cites W3084132078 @default.
• W4289833892 cites W3126223420 @default.
• W4289833892 cites W3135666978 @default.
• W4289833892 cites W3185550549 @default.
• W4289833892 cites W3208538596 @default.
• W4289833892 cites W3210820793 @default.
• W4289833892 cites W4200117800 @default.
• W4289833892 cites W4200457203 @default.
• W4289833892 cites W4200459022 @default.
• W4289833892 cites W4242546620 @default.
• W4289833892 doi "https://doi.org/10.1016/j.eururo.2022.07.011" @default.
• W4289833892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35934601" @default.
• W4289833892 hasPublicationYear "2022" @default.
• W4289833892 type Work @default.
• W4289833892 citedByCount "22" @default.
• W4289833892 countsByYear W42898338922022 @default.
• W4289833892 countsByYear W42898338922023 @default.
• W4289833892 crossrefType "journal-article" @default.
• W4289833892 hasAuthorship W4289833892A5005238316 @default.
• W4289833892 hasAuthorship W4289833892A5008514077 @default.
• W4289833892 hasAuthorship W4289833892A5014871240 @default.
• W4289833892 hasAuthorship W4289833892A5015145551 @default.
• W4289833892 hasAuthorship W4289833892A5016754892 @default.

• next